Literature DB >> 5653217

Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital.

J H Oppenheimer, G Bernstein, M I Surks.   

Abstract

Administration of phenobarbital to rats in a dosage schedule previously demonstrated to increase hepatocellular binding of thyroxine results in increased hormonal turnover, due both to increased deiodination and to fecal disposition of thyroxine iodine. The rate of biliary excretion of thyroxine iodine is roughly proportional to the hepatic content of exchangeable thyroxine. The enhanced peripheral disposition of thyroxine appears to lead to increased thyroidal function, as measured by isotopic iodine studies, and the maintenance of a normal nonradioactive serum PBI. On the other hand, thyroidectomized animals maintained on a constant replacement dose of L-thyroxine and treated with phenobarbital exhibit a marked fall in serum PBI. These findings suggest that increased thyroxine flux in phenobarbital-treated animals is secondary to primary stimulation of hepatocellular binding. Exchangeable intracellular thyroxine may thus be an important determinant of hormone turnover and, possibly, of hormonal action.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5653217      PMCID: PMC297295          DOI: 10.1172/JCI105831

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  Estimation of thyroxine secretion rate in the rat by the radioactive thyroxine turnover technique: influences of age, sex and exposure to cold.

Authors:  R I GREGERMAN
Journal:  Endocrinology       Date:  1963-03       Impact factor: 4.736

2.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

3.  Further investigations on the effect of prominal on thyroid function of the rat.

Authors:  F SCHWARZ; P J DER KINDEREN; J L VAN HAAFTEN; L E KOOPMAN
Journal:  Acta Endocrinol (Copenh)       Date:  1955-08

4.  Thyroxine turnover and transport in active acromegaly.

Authors:  M Inada; K Sterling
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

5.  Analysis of the rapid interchange of thyroxine between plasma and liver and plasma and kidney in the intact rat.

Authors:  J Hasen; G Bernstein; E Volpert; J H Oppenheimer
Journal:  Endocrinology       Date:  1968-01       Impact factor: 4.736

6.  The kinetics of distribution between plasma and liver of 131-I-labeled L-thyroxine in man: observations of subjects with normal and decreased serum thyroxine-binding globulin.

Authors:  R R Cavalieri; G L Searle
Journal:  J Clin Invest       Date:  1966-06       Impact factor: 14.808

7.  Hepatic accumulation of 125I-thyroxine in the rat: augmentation by phenobarbital and chlordane.

Authors:  G Bernstein; S A Artz; J Hasen; J H Oppenheimer
Journal:  Endocrinology       Date:  1968-02       Impact factor: 4.736

8.  Serum free thyroxine and thyroxine binding proteins in male adolescents.

Authors:  P Malvaux; P De Nayer; C Beckers; H G Van den Schrieck; M De Visscher
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

9.  Factors affecting exchange of thyroid hormones between liver and blood.

Authors:  C A Gorman; E V Flock; C A Owen; J Paris
Journal:  Endocrinology       Date:  1966-08       Impact factor: 4.736

10.  Estimation of rapidly exchangeable cellular thyroxine from the plasma disappearance curves of simultaneously administered thyroxine-131-I and albumin-125-I.

Authors:  J H Oppenheimer; G Bernstein; J Hasen
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

View more
  26 in total

1.  Levothyroxine replacement doses are affected by gender and weight, but not age.

Authors:  Madhuri Devdhar; Rebecca Drooger; Marieta Pehlivanova; Gurdeep Singh; Jacqueline Jonklaas
Journal:  Thyroid       Date:  2011-07-13       Impact factor: 6.568

2.  Polybrominated diphenyl ether (DE-71) interferes with thyroid hormone action independent of effects on circulating levels of thyroid hormone in male rats.

Authors:  Ruby Bansal; Daniel Tighe; Amin Danai; Dorothea F K Rawn; Dean W Gaertner; Doug L Arnold; Mary E Gilbert; R Thomas Zoeller
Journal:  Endocrinology       Date:  2014-07-25       Impact factor: 4.736

3.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children.

Authors:  F De Luca; T Arrigo; E Pandullo; M F Siracusano; S Benvenga; F Trimarchi
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

5.  Reports of two cases of autoimmune thyroiditis while receiving anticonvulsant therapy.

Authors:  S Nishiyama; M Matsukura; S Fujimoto; I Matsuda
Journal:  Eur J Pediatr       Date:  1983-04       Impact factor: 3.183

6.  The prognostic value of thyroid function tests in predominantly non-alcoholic cirrhotic patients: a prospective investigation.

Authors:  G D'Azzò; G B Pinzello; F Pace; P Garofalo; A Craxì; A Jannì
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

7.  Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine.

Authors:  J M Connell; W G Rapeport; S Gordon; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Anticonvulsants and thyroid function.

Authors:  P P Yeo; D Bates; J G Howe; W A Ratcliffe; C W Schardt; A Heath; D C Evered
Journal:  Br Med J       Date:  1978-06-17

9.  Differences in primary cellular factors influencing the metabolism and distribution of 3,5,3'-L-triiodothyronine and L-thyroxine.

Authors:  J H Oppenheimer; H L Schwartz; H C Shapiro; G Bernstein; M I Surks
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

10.  Effect of barbital on the pituitary-thyroid axis.

Authors:  M Ching
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.